The third human tissue kallikrein to be identified, hK2, could be an alternate or complementary marker to kallikrein hK3 (prostate-specific antigen) for prostate diseases. Most of the hK2 in seminal plasma forms an inactive complex with protein C inhibitor (PCI), a serpin secreted by seminal vesicles. As serpin inhibitors behave as suicide substrates that are cleaved early in the interaction with their target enzyme, and kallikreins have different sensitivities to serpin inhibitors, we prepared a series of substrates with intramolecularly quenched fluorescence based on the sequences of the serpin reactive loops. They were used to compare the substrate specificities of hK1 and hK2, which both have trypsin-like specificity, and thus differ from chymotrypsin-like hK3. The serpin-derived peptides behaved as kallikrein substrates whose sensitivities reflected the specificity of the parent inhibitory proteins. Substrates derived from PCI were the most sensitive for both hK1 and hK2 with specificity constants of about 10 7 M ؊1 . s ؊1 . Those derived from antithrombin III and ␣ 2 -antiplasmin were more specific for hK2 while a kallistatin-derived substrate was specifically cleaved by hK1. hK1 and hK2 substrates of greater specificity were obtained using chimeric peptides based on the sequence of serpin reactive loops.The main difference between specificities of hK1 and hK2 arise because hK2 can accommodate positively charged as well as small residues at P 2 and requires an arginyl residue at P 1 . Thus, unlike hK1, hK2 does not cleave kininogen-derived substrates overlapping the region of N-terminal insertion of bradykinin in human kininogens.The human kallikrein gene family contains three well-characterized members, hKLK1, hKLK2 and hKLK3 (1). These genes have been mapped to chromosome 19 (2) and are translated to give rise to proteinases hK1, hK2, and hK3 respectively (1). The only human tissue kallikrein with an undisputed function is hK1, which releases vasoactive kinins from kininogens, but these proteinases may have several other functions, including the processing of hormone and other peptide precursors (reviewed in Refs. 3 and 4). hK3 is produced mainly in the prostate and is known essentially as a marker of prostatic diseases (see Ref. 5 for a recent review). It participates in sperm liquefaction by cleaving fibronectin and semenogelins, the major components of the seminal vesicle coagulum after ejaculation (6, 7) and possibly in the processing of IGFBP-3 1 (8). hK2 is also predominantly synthesized in the prostate epithelium. Its mRNA concentration in the prostate gland is 4 -7 times lower than that of hK3 (9, 10), and it is present in seminal plasma as high M r inactive complexes with protein C inhibitor and as low M r inactive fragments (11). Its biological function remains unknown, but it has been suggested that it participates in the liquefaction of seminal coagulum (12). Interest has recently focused on this protein since it appears to be a novel marker of prostate cancer and/or benign prostate adenoma (...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.